Insight

Talha Badar: Transplant or no transplant for TP53 mutated AML

Talha Badar/X

Oct 5, 2024, 11:39

Talha Badar: Transplant or no transplant for TP53 mutated AML

Talha Badar shared a post on X about a recent paper titled “Transplant or no transplant for TP53 mutated AML” published in Oncotarget.

Authors: Talha Badar, Moazzam Shahzad, Ehab Atallah, Mark Litzow, Mohamed Kharfan-Dabaja

“Transplant or no transplant for TP53 mutated AML.”

Source: Talha Badar/X

Acute Myeloid Leukemia AML cancer Ehab Atallah Mark Litzow Moazzam Shahzad Mohamed Kharfan-Dabaja OncoDaily Oncology Oncotarget Talha Badar

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Drugs

Dec 21, 2024, 10:38

Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024

Insight

Dec 21, 2024, 10:35

30 Years of Leadership in Immuno-Oncology - Agenus

Blog

Dec 21, 2024, 10:19

A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil

Dialogues

Dec 21, 2024, 10:09

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Blog

Dec 21, 2024, 09:22

When the world of science and sports comes together! - The V Foundation

Blog

Dec 21, 2024, 09:16

Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation

Science

Dec 21, 2024, 09:06

Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial

Blog

Dec 21, 2024, 09:00

Miriam Mutebi: Does Nipple and Areola Size Matter?

Science

Dec 21, 2024, 08:51

Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis

Science

Dec 21, 2024, 08:48

Oncology Brothers: Another ALK inhibitor gets FDA approval

Science

Dec 21, 2024, 08:42

Eric K. Singhi: Decoding clinical trial jargon

Science

Dec 21, 2024, 08:37

Gustavo Viani: The Role of Radiotherapy on the management of HCC